AtriCure, Inc. (ATRC)
Last updated: 2026-10-24 13:37:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
AtriCure, Inc. (ATRC) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $59.04, with a market capitalization of $3.02B and a P/E ratio of 285.86. Over the past 52 weeks, its price has ranged from $25.36 to $61.70. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.02B | |
$58.94 | |
$89.18 | |
$1.00 | |
$59.30 | |
353.62K | |
1.04M | |
285.86 | |
$61.70 | |
$25.36 | |
-- | |
-- |
AtriCure, Inc. (ATRC) Latest Closing Stock Price
AtriCure, Inc. (ATRC) last closed at $59.30 as of 2026-10-23 23:31:00, unchanged from the previous close of $59.30.
During the latest regular trading session, ATRC traded between $1.00 and $89.18, with a volume of 353.62K shares. The closing price was near the upper end and near the upper end of its 52-week range.
AtriCure, Inc. (ATRC) 7-Day Stock Price Change
Over the past seven days, AtriCure, Inc. (ATRC) moved from $57.78 to $59.04, representing a gain of 2.18% ($1.26).
The stock traded between $55.16 and $59.56 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 587.79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ATRC 52-Week Price Position
Position in Range: 92.7%
ATRC is currently trading at $59.04, placing it 92.7% of the way from its 52-week low of $25.36 to its 52-week high of $61.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is AtriCure, Inc. (ATRC)?
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
AtriCure, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1350 |
| Exchange | NASDAQ |
| Company Website |
How to Buy AtriCure, Inc. (ATRC) Stock on MEXC
Eligible investors can buy real shares of AtriCure, Inc. (ATRC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is AtriCure, Inc. (ATRC) stock price today?
2.Is ATRC stock going up or down today?
3.What is ATRC pre-market price?
4.What is ATRC after-hours price?
5.Is ATRC stock trading now?
6.Where does ATRC sit relative to its 52-week high and low?
7.What sector is AtriCure, Inc. in?
8.What is AtriCure, Inc.'s market capitalization and where is it listed?
9.How is ATRC valued in terms of P/E ratio and EPS?
10.Does AtriCure, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ATRC Stock Calculator
Estimate the value between ATRC shares and USD.
ATRC Shares to USD
1.00 ATRC shares = 59.037 USD
Calculations are estimates based on the latest available price and are for reference only.


